70 results
Page 2 of 4
424B3
wf7ic 3z5l1t
5 Sep 23
Prospectus supplement
4:16pm
F-1
mwwvwdk46mzuv34i
25 Aug 23
Registration statement (foreign)
4:15pm
6-K
EX-99.2
coj7ayzf51l9psifci2
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.3
9cknhsn1vo50xy7vz86
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.1
e5vtlgzc w7g3
19 Jul 23
Current report (foreign)
9:08am
424B5
bvsig
18 Jul 23
Prospectus supplement for primary offering
11:59am
6-K
EX-99.1
48zasfx9 3gc9pjnd55
14 Jul 23
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct
3:45pm
424B5
nunrvgo78ha e25
14 Jul 23
Prospectus supplement for primary offering
12:26pm
6-K
EX-99.1
zoy zct2tgl06f8v0b
12 Jul 23
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
9:23am
6-K
EX-99.1
uko5ea
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
EX-99.1
tc2j2 45zk
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
EX-99.2
zvpksx iuar
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.3
5hx2wnqe 462salahfj
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.1
iahimvklx5
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
EX-99.1
z68j036wnvbiwptj7df
15 Nov 22
PainReform Provides Business Update for the Third Quarter of 2022
8:47am
6-K
EX-99.2
ypwrk
14 Nov 22
Condensed Financial Statements
5:02pm
6-K
EX-99.1
xcqqm4bu3bq
8 Nov 22
PainReform Provides Further Update on Manufacturing of PRF-110
8:42am
6-K
EX-99.1
24uq6ippqjgmb7 7aoo
4 Oct 22
PainReform Provides PRF-110 Manufacturing Update
10:21am
6-K
EX-99.1
7pbu8k yc
16 Aug 22
PainReform Announces Receipt of Nasdaq Minimum Bid Price Notification
8:08am
6-K
EX-99.3
pfyi5s j4g
15 Aug 22
Current report (foreign)
6:16pm